ARCHIVES

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

This article is from The Cancer Letter archive.

Vol. 04 No. 01 | January 6, 1978

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week.

May 14, 2004

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978